Search results
Results from the WOW.Com Content Network
Prior to studying medicine, Robert Malone studied computer science at Santa Barbara City College for two years, acting as a teaching assistant in 1981. [2] [8] He received his BS in biochemistry from the University of California, Davis in 1984, his MS in biology from the University of California, San Diego in 1988, and his MD from Northwestern University Feinberg School of Medicine in 1991.
Timeline of some key discoveries and advances in the development of mRNA-based drug technology. The first successful transfection of designed mRNA packaged within a liposomal nanoparticle into a cell was published in 1989. [18] [19] "Naked" (or unprotected) lab-made mRNA was injected a year later into the muscle of mice.
Hoerr did experimental research on the stabilization of messenger ribonucleic acid (mRNA). In 1999, he received his PhD from Günther Jung, Institute of Organic Chemistry, in cooperation with Hans-Georg Rammensee, Institute of Immunology and Cell Biology (both: University of Tübingen) on the topic of RNA vaccines for the induction of specific cytotoxic T lymphocytes (CTL) and antibodies.
Two pioneering scientists who created the technology behind life-saving Covid-19 vaccines have won the Nobel Prize in medicine or physiology.
For premium support please call: 800-290-4726 more ways to reach us
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
[1] [2] As of 2021, the article has been cited in the scholarly press more than 630 times and been described, by Nature, as "the first step toward making a vaccine from mRNA". [3] [4] Wolff was born in Bayside, Queens, New York, in 1956, [5] [6] received his undergraduate education at Cornell University and earned an MD from Johns Hopkins ...
Initially, MacLachlan and Tekmira turned away from the collaboration. Karikó wanted to team up with Ian MacLachlan because he was the leader of a team that helped advance mRNA technology. Karikó was working on establishing the formulated lipid nanoparticle delivery system that encapsulates mRNA in a dense particle through a mixing process ...